Business Strategies
Medtronic’s Long Commitment to RDN May Finally Pay Off
Medtronic’s renal denervation business is preparing for US-wide expansion now that the therapy is FDA approved to treat uncontrolled hypertension and reimbursed by Medicare nationwide.
Read Article